Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average rating of “Buy” by the nine ratings firms that are ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase first identified in a chromosomal translocation associated with some anaplastic large cell lymphomas (ALCL), a subset of T-cell non ...

S.M. Thomas, M. DeMarco, G. D'Arcangelo, S. Halegoua, J.S. Brugge, "Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of ...

Aberrant activation of the Ras/Raf/MAPK/ERK kinase/extracellular ... Sorafenib is an oral tyrosine kinase inhibitor able to inhibit VEGF receptors 1, 2 and 3, PDGF receptors α and β, RET ...

B cells have been implicated in disease progression and as such represent an attractive therapeutic target. Lyn is a Src family tyrosine kinase that plays a major role in regulating signaling pathways ...

In addition, HER2 activation can activate Ras/Raf and MEK pathways, which favors cancer cells’ growth and migration. Trastuzumab has been proposed to trigger HER2 internalization and degradation ...

RPSC has announced the RAS Prelims Exam 2024 will be held on February 2, 2025, from 12 noon to 3 pm. Admit cards will be available on January 30, 2025. Registered candidates can download their ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...